09/14/2010

Pantene Helping the Women’s Cancer Research Fund with Jamie Tisch

The Women’s Cancer Research Fund, co-founded by Kelly Chapman Meyer, Marion Laurie, Anne Douglas, Quinn Ezralow and Jamie Tisch, relies on the generous donations of many to continue doing their important work.  One of their major donors is Pantene, the famous hair care product company.

Pantene started in 1947 and was owned by a Swiss drug company Hoffman-LaRoche. Pantene arrived in the United States in the 1960s and continued its popularity there.  In the 1980s they had some of the most popular campaigns ever, including the “Don’t hate me because I’m beautiful” campaign. They were purchased by Procter and Gamble in 1985 and they expanded their distribution on a massive scale at that time. By 1995, they had become a billion dollar brand and, today, they have over 100 hair care and hair styling products.

Certainly, the Women’s Cancer Research Fund with Jamie Tisch appreciates the support of Pantene to help in the fight against women’s cancers.

Sep 14, 2010 1:57:38 AM | cancer research, charity, Jamie Tisch

The comments to this entry are closed.

NEXT POST
Getting to the Know the Major Donors of the WCRF Certainly, the Women’s Cancer Research Fund, started by Kelly Chapman Meyer, Marion Laurie, Anne Douglas, Quinn Ezralow and Jamie Tisch, appreciates the commitment offered by its major donors. With their help, the WCRF is able to pursue their many goals and continue working towards cures for cancer. As a major donor, philosophy is committed to helping women to look their best, and to be their most healthy. Prior to founding philosophy, Christina Carlino had a skin care company called biomedic which was a medically-based skin care line that was distributed to the world’s leading plastic surgeons and dermatologists. With philosophy, she wanted to bridge the gap between what was offered in the doctors’ offices and retail.
PREVIOUS POST
Use of Hormone Therapy in Breast Cancer Prevention Recent studies have shown that the long-term use of hormone therapy (often used for menopausal symptoms) show an increased risk for contracting breast cancer. Those taking the drug should discuss other options with their physician. If you do decide it’s best for you to continue with the drug however, at least consider lowering the dosage or switching to a temporary (not long-term) usage of it. While taking the drug may reduce extremely unpleasant menopausal symptoms, it might not be worth the risk that it comes with vis-à-vis the possibility of contracting breast cancer. There are other options available, including alternative remedies that won’t come with these added complications so it is definitely worth investigating the successes of these. The Women’s Cancer Research Fund – of which Jamie Tisch is a co-founder – is constantly looking toward better methods and ways of reducing the potential of contracting breast cancer.